IFITM3 requires an amphipathic helix for antiviral activity
Related Experiment Video
Updated: Feb 24, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Nicholas M Chesarino1, Alex A Compton2,3,4, Temet M McMichael1
1Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA.
Abstract:
Interferon-induced transmembrane protein 3 (IFITM3) is a cellular factor that blocks virus fusion with cell membranes. IFITM3 has been suggested to alter membrane curvature and fluidity, though its exact mechanism of action is unclear. Using a bioinformatic approach, we predict IFITM3 secondary structures and identify a highly conserved, short amphipathic helix within a hydrophobic region of IFITM3 previously thought to be a transmembrane domain. Consistent with the known ability of amphipathic helices to alter membrane properties, we show that this helix and its amphipathicity are required for the IFITM3-dependent inhibition of influenza virus, Zika virus, vesicular stomatitis virus, Ebola virus, and human immunodeficiency virus infections. The homologous amphipathic helix within IFITM1 is also required for the inhibition of infection, indicating that IFITM proteins possess a conserved mechanism of antiviral action. We further demonstrate that the amphipathic helix of IFITM3 is required to block influenza virus hemagglutinin-mediated membrane fusion. Overall, our results provide evidence that IFITM proteins utilize an amphipathic helix for inhibiting virus fusion.
Insights
Interferon-induced transmembrane protein 3 (IFITM3) uses a specific helix to block viruses from entering cells. This amphipathic helix is crucial for IFITM3
Area of Science:
- Virology and Molecular Biology
- Cellular and Membrane Biology
- Bioinformatics and Structural Biology
Background:
- Interferon-induced transmembrane protein 3 (IFITM3) is a key cellular antiviral factor.
- IFITM3's mechanism for blocking virus-cell membrane fusion remains incompletely understood.
- Previous research suggested IFITM3 functions within transmembrane domains.
Purpose of the Study:
- To elucidate the precise mechanism by which IFITM3 inhibits viral entry.
- To identify structural elements within IFITM3 critical for its antiviral activity.
- To determine if this mechanism is conserved across different IFITM proteins.
Main Methods:
- Bioinformatic analysis to predict IFITM3 secondary structures.
- Identification and characterization of a conserved amphipathic helix.
- Functional assays using various viruses (influenza, Zika, VSV, Ebola, HIV) to assess antiviral inhibition.
Main Results:
- A conserved, short amphipathic helix was identified in a previously assumed transmembrane region of IFITM3.
- This amphipathic helix is essential for IFITM3's broad-spectrum antiviral activity against multiple viruses.
- The homologous helix in IFITM1 is also required for antiviral function, suggesting a conserved mechanism.
Conclusions:
- IFITM proteins, including IFITM3, employ a conserved amphipathic helix mechanism to inhibit virus fusion.
- This helix directly interferes with viral hemagglutinin-mediated membrane fusion.
- The findings reveal a novel structural basis for IFITM-mediated antiviral defense.
Related Concept Videos
Retroviruses
Leaky Scanning
Viral Structure
Retrovirus Life Cycles

